420 with CNW – Mexican Supreme Court Extends Marijuana Legalization Deadline

The Mexican Supreme Court has extended the deadline for marijuana legalization, which it made last year when lawmakers were given up to  October 31 to change the policy on prohibition of personal use or cultivation of marijuana by terming it unconstitutional.

The previous ruling had stipulated that the policy be changed by  October 31, but it has now been extended to April 30, 2020.

The Mexican Supreme Court granted the extension on Tuesday but publicized it on Friday. Last week, the committee submitted a comprehensive marijuana legalization bill to the Senate. Due to the additional time granted by the Supreme Court, the Senate is going to break down the legalization bill and begin debates on it this week.

The lawmakers requested the extension on Tuesday last week after seeing that it would be impossible to conclude the debate and vote before October 31. Their motion of deadline extension was approved by the court, which noted the complexity of the process. They also observed that the circumstances for the request were unique and exceptional.

Some of the concerns to be discussed by the lawmakers include the monopolization of the marijuana industry by multinational marijuana corporations once they join the legal market. Marijuana advocates have also complained about the strict policies regarding the number of marijuana plants to be cultivated at home.

The legislation which was approved last week by the committees stipulated that 20% of the licenses be awarded to economically disadvantaged persons. The bill also stated that people who are 18 years and above could possess, purchase, and consume marijuana. It also allowed people to cultivate up to four marijuana plants.

Since the Supreme Court ruling, the legislators have been submitting various bills that were used to make the legislative reforms. The policies were also developed from the input gathered from the solicited public information on reform proposals.

The Senate might add several policies to the legislation since they have six months to act on the legislative reform. The Senate Health committee also filed a new bill this week. The bill might be added to the proposed changes because the advocates feel that it is an improvement to the last proposal, which was to be voted on. For instance, the new legislation allows people to grow a maximum of 6 plants and possess a maximum of 30 grams of marijuana; however, the new bill prohibits edibles and THC-infused beverages.

The Mexican Senate has not reached a consensus about marijuana legalization in the country and how it should look. But, the leaders still insist that they are close to finalizing the comprehensive marijuana legalization plan. The Senate leader of the MORENA Party, Senator Monreal, said that the Senate would vote on the bill in the first weeks of November. However, after the Supreme Court extended the deadline by several months, it is not yet clear if he will also extend further.

After approval by the Senate, the legislation will be forwarded to the Chamber of Deputies and, finally, the president’s desk.

It would be interesting to learn what established cannabis companies like Neutra Corp. (OTC: NTRR) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) have to say about the possible regional implications of marijuana legalization in Mexico.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

HempNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Discusses Strategic Hemp, CBD Focus on MoneyTV with Donald Baillargeon

Established financial news and investment portal ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang recently discussed the focus of the company on “MoneyTV” with Donald Baillargeon (http://cnw.fm/6yrEt). An article discussing the company reads, “Wang notes that ChineseInvestors.com helps its clients expand their shareholder base. Additionally, the company’s subscription division, a live broadcast set during market hours, allows members to connect with professors who are experienced in navigating the stock market. He added that members enjoy this interactive program and appreciate the education provided in how to trade options on the market. This valuable program is enabling ChineseInvestors.com to build its customer and investor database. . . . While the company continues to roll out new products and services, its present plan is to emphasize its original mission of providing financial information and services to the larger Chinese community in the United States and elsewhere (http://cnw.fm/RZ9mA). With offices in San Gabriel, California; Flushing, New York; and Shanghai, China, ChineseInvestors.com is well positioned to achieve this goal. ‘While we have been strategically focusing on industrial hemp and CBD sales, we are pleased with the progress we have seen in our legacy businesses, financial news, education subscriptions, and investor relations, where we are refocused on organic growth,’ Wang said recently.”

To view the full article, visit http://cnw.fm/94urZ

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Advancing Strategy to Become Leading Extraction, Distillation, Refining Operator

HTC Extraction Systems (TSX.V: HTC) is utilizing its ethanol-based distillation experience to establish itself as one of the largest extraction, distillation and refining operators in North America. An article discussing the company reads, “HTC has built a 19,000-square-foot extraction facility in Port Lajord, Saskatchewan, near the metropolitan Regina commerce center. The facility will provide the commissioning for newly installed biomass processing, extraction, distillation and refining equipment, utilizing the corporation’s DeltaSolv(TM) technologies and Delta Purification(R) systems. . . . The facility will also house laboratory quality control and testing operations, as well as onsite administration offices. HTC is also engaged in preliminary due diligence investigations that would expand its operations into the United States, where the company seeks to replicate its model of using hemp biomass tolling contracts with producers and other providers to begin extraction for the 2020 hemp crop growing year in an as-yet-to-be-determined location.”

To view the full article, visit http://cnw.fm/R8fwY

About HTC Extraction Systems

HTC Extraction Systems has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp-biomass and cannabidiol (“CBD”) industry as well as gas and liquid extraction. HTC’s extraction and purification systems are engineered to large scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced. For more information, visit the company’s website at www.HTCExtraction.com.

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://cnw.fm/HTC

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Broadens Portfolio via Acquisition of Zoots Premium Cannabis

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a Tacoma, Washington-based cannabis holding company, recently acquired Zoots Premium Cannabis and its assortment of drops, gummies, energy shots and hard candies (http://cnw.fm/DeI1B). An article discussing the company reads, “The West Coast-based companies acknowledged a February Zion Market Research report that valued the global cannabis edibles market at approximately $2.4 billion in 2018 with expected revenues of about $11.6 billion by 2025 at a CAGR of around 25.4% between 2019 and 2025 (http://cnw.fm/Re2pI). . . . IONIC also entered the infused-beverage market with secured patents in the single-serve coffee and beverage-pod market during the spring. The announced patents are among the first cannabis patents in the country’s history, slated for brewing cannabis-infused coffee, tea and cocoa from CannaCafe (http://cnw.fm/qht7O) — a potential multibillion-dollar market in its own right.”

To view the full article, visit http://cnw.fm/yVXv5

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused, cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington state and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands’s strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – WeedMD Inc. (TSX.V: WMD) (OTCQX: WDDMF) (FSE: 4WE) Posts Corporate Update, Schedules Q3 Earnings Conference Call

WeedMD (TSX.V: WMD) (OTCQX: WDDMF) (FSE: 4WE), a federally licensed producer and distributor of medical-grade cannabis, this morning issued an operational update. Per the update, the company has successfully completed the harvest of its 27-acre crop of outdoor cannabis at its Strathroy facility. WeedMD intends to provide metrics, including total yield of the harvest, in conjunction with its upcoming earnings announcement. The company also detailed its entrance into commercial extraction operations at its Aylmer facility, where it has obtained a Health Canada license to produce and sell cannabis concentrates, edibles and topicals. Among other highlights, the press release also included updates regarding ongoing test results, CX Industries’ processing capability and its entrance into commercial operation. In addition, WeedMD announced that it will release its third quarter 2019 financial results after market close on Thursday, November 28, 2019. The company will hold a conference call hosted by CEO Keith Merker and CFO Nichola Thompson at 10 AM ET on Friday, November 29, 2019. Call-in details will be issued in the coming weeks. “With the outdoor harvest now complete, we’ve achieved a significant milestone. WeedMD now has a significant amount of cannabis that we intend to bring to market over the current and coming quarters as both dried flower and in various value-added formats,” WeedMD CEO Keith Merker stated in the news release. “Combining our vertically-integrated extraction business at our CX Industries site in Aylmer with our low-cost production of dried flower, we are well positioned to emerge as a leader in the production and sale of extracts.”

To view the full press release, visit http://cnw.fm/5MxkE

About WeedMD Inc.

WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc. CX Industries operates out of the company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where WeedMD’s adult-use brand Color Cannabis is sold. For more information, visit the company’s website at www.WeedMD.com.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Begin Trading on the OTCQB® Venture Market

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced that it has been approved to commence trading on the OTCQB® Venture Market (the “OTCQB”), under the symbol “CANSF,” beginning today, November 5, 2019. The listing will enable Willow Biosciences access to a broader base of U.S. and international retail and institutional investors, ultimately providing increased data access, transparency and liquidity to investors. “Listing on the OTCQB will allow for greater engagement with our U.S. investor base,” Willow CEO Trevor Peters said in the news release. “As we move towards scale up of ultra-pure, pharmaceutical grade cannabidiol (“CBD”) with our partner Noramco, Inc., we are happy to provide U.S. investors with an easier platform to invest in our company.”

To view the full press release, visit http://cnw.fm/gQU9a

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CBDWire

CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CBDW? Ask our Editor

CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Names New Senior Advisor

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, this morning announced the appointment of Gregg Smith as a Senior Advisor for the company. Smith is the founder of Evolution VC Partners (www.EvolutionVCP.com), a New York-based “culture tech” venture investment firm with over 90 portfolio companies. Through his LLC, Smith is acquiring an equity position in LXRP by participating in the company’s recently announced private placement financing of $0.45 units. “I am passionate about creating a smokeless future and recognize that the consumption methods of nicotine and cannabis will change. Lexaria’s technology, DehydraTECH(TM), will completely disrupt and improve the consumption and delivery of oral nicotine, CBD and cannabis,” Senior Advisor Gregg Smith stated in the news release. “Lexaria’s recognition of the recent FDA recognition of certain oral delivery forms of nicotine as ‘less harmful’ to human health than combustible smoking will be a driving force of changing consumer preferences. I expect Lexaria’s technology to play a significant role in that future and I am pleased to advise the management team at Lexaria in defining our leadership strategies.”

To view the full press release, visit http://cnw.fm/jNhW4

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug-delivery platforms. Its patented DehydraTECH(TM) drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Strange But True: Marijuana Retrieved from Man’s Nose After 18 Years

Doctors found marijuana in a man’s nose 18 years after he inserted it in his nostrils in an attempt to smuggle it into prison. Doctors have termed it as the first case of this nature.

The team reporting on the case in the British Medical Journal said that the man’s girlfriend brought him the drugs wrapped in a ballon while visiting him in prison. To evade being caught by the guards, he hid the drugs in his nostrils. However, in the process of hiding the drugs, he pushed them too far into the nasal cavity, making it impossible to dislodge.

The man believed that he ingested the drugs, so he never suspected the drug to be the cause of the chronic sinus infections, not even when he had symptoms of nasal obstructions years after the incident.

During the period of incarceration (18 years), the drugs developed into a rhinolith. A rhinolith is a mass of calcium and magnesium salts that form around an alien element in the nasal cavity.

The man went to the hospital after suffering from a sinus infection, and that is when the rhinolith was discovered, Westmead Hospital in Sydney (Australia) doctors said.

Since the 48-year-old man was complaining of headaches, the doctors did a CT of the brain and they discovered a rhinolith measuring 19x11mm in the man’s nasal cavity. The doctors then referred him to the Westmead ENT Department.

After following up with questions to determine the cause of the calcified lesion, the man admitted to having hidden drugs in his nose. He also said that he had been suffering from nasal obstruction and recurring sinus infection for several years.

The man was put under general anesthesia, and the rhinolith was removed. A study on the calcified lesion showed that it contained a rubber wrapping whose content was disintegrated vegetable material.

According to the report, the man remembered the incident that occurred in prison 18 years ago after being taken through a series of questions. The man had forgotten about the drugs and only remembered after the histopathology report. He was free of nasal discomfort three months after the calcified lesion was removed.

The researchers said that this is the first case where a man gets a marijuana-based rhinolith in prison. The researchers further said most cases of drug smuggling in prison take place through oral ingestion, and later retrieved through the gastrointestinal tract. It is rare to find an example of nasal smuggling, said the researchers.

Foreign objects in the body such as beads or seeds or bodily matter such as dislodged teeth or blood clots can be turned into rhinoliths when a mass of calcium and magnesium salt covers them.

Rhinoliths are very rare. According to the study, in every 10,000 ears, noses, or throats, one rhinolith is found in outpatient visits. Patients with rhinoliths complain of symptoms such as headaches, facial pain, nasal blockage, and nose discharge.

Industry wtachers believe that marijuana companies like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Sugarmade Inc. (OTCQB: SGMD) must be surprised at an inmate went to such great lengths to smuggle weed into jail.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Senate Approves Bill Banning Feds from Interfering in Medical Marijuana State Programs

On Thursday, the Senate passed the spending legislation which has a provision that ensures that medical marijuana states are protected from federal interference. However, the question on everyone’s mind is if the bill will be signed into law once it gets to the president’s office.

The spending legislation is also referred to as minibus appropriation as it covers funding for Agriculture, commerce, Environment, Food, and Drug Administration, Housing, Interior, Justice, Military Construction, Rural Development, Science, Veteran Affairs, Transportation and Urban Development for the 2020 financial year.

The vote on the bill was overwhelming, with 84 in favor vs. 9 votes against. The legislation also had language related to new hemp and CBD.

The legislation prohibits the Department of Justice from using its resources to persecute persons whose actions comply with state marijuana regulations.

In June, the House approved the Justice Department Appropriation bill which would extend protection to all Cannabis programs including  recreational use and sale in the legalized states in the U.S. Marijuana advocates are hopeful that the Senators will approve the legislation; however, in an interview with some media outlets, some Senators said that it is unlikely for the added policies to be adopted because of the bicameral agreement made by the Congressional leaders which stipulated that no new policy riders are to be added during the appropriation process unless agreed on a bipartisan basis.

If the bicameral conference committee negotiators agree to use the House language in the final legislation, the Senate will send the amended bill to the president’s desk for 2020. If, by 21st November, the spending bill is not signed into law, the government will cease operations. Therefore, to avoid such an incident, the larger chambers may opt to approve the bill previously passed by the Senate.

The political director of NORML, Justin Strekal, said he hopes the House will insist on the inclusion of the provision restricting the feds from interfering with marijuana programs in the legalized states in the minibus spending legislation.

Last week, a separate amendment was added to the minibus appropriation bill by Senator Bob Menedez, calling on the Attorney General to review the criminal justice effects of marijuana legalization. However, the Senate did not consider nor discuss the measure.

Apart from the marijuana protection language, the Senate Appropriations Committee also advanced other policies through the spending process. They approved legislation with additional policies that barred Washington from using the local resources, such as tax revenue, to develop a legal marijuana market. It also approved a provision granting funds to the Department of Agriculture to sanction rules for legal hemp program.

In the House version of the appropriations bill, lawmakers also approved a provision for issuing protection to the banks doing business with the marijuana industry, as well as the removal of the measure barring D.C. from implementing a marijuana market.

The majority of the Senate is Republican, and they are sticking with the bicameral agreement; this may lead to the formation of standalone cannabis legislation, such as the SAFE Banking Act, which would allow banks to work with weed businesses without interference from the Department of Justice.

Analysts are of the view that the entire cannabis industry, including Marijuana Company of America Inc. (OTCQB: MCOA) and VPR Brands LP (OTCQB: VPRB), is waiting with bated breath to see how the final vote on the bill goes.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – OrgHarvest, Inc. (OTC: ORGH) Receives SEC Approval to Extend Reg A+ Offering

OrgHarvest (OTC: ORGH), the first U.S. based cannabis cultivation company to achieve a Regulation A+ qualification, today announced approval from the Securities and Exchange Commission (“SEC”) for a 12-month extension on OrgHarvest’s Reg A+ Offering. According to the update, the company’s management indicated that the timing of this extension was nearly perfect, particularly as OrgHarvest has completed and filed with the SEC a GAAP Audit via Black Rock Consulting in anticipation of becoming a fully reporting company. OrgHarvest plans to upgrade its securities to the OTCQB at the end of 2019 via a PCOAB audit. “Things are all slowly falling into place… And, once we finalize a few of the larger deals that we’re currently working on, things should quickly expand on all fronts – including shareholder confidence,” OrgHarvest CEO Frank Celecia said in the news release. “We are extremely thankful to the SEC for approving us for another 12 months and will continue to aggressively push our Reg A+ offering forward.”

To view the full press release, visit http://cnw.fm/A5F5o

About OrgHarvest, Inc.

OrgHarvest’s competitive advantages include risk diversification through the approach of growing cannabis using a high-tech, custom-made, Dutch glasshouse manufactured in the Netherlands, which offers a unique combination of advantages unmatched by OrgHarvest’s competitors. Compared to other cannabis operations, the company differentiates itself by offering a facility that can provide better quality flowers, pest-free growing conditions, and a stronger focus on developing strains and new products using exclusive patented technology. For more information, visit the company’s website at www.OrgHarvest.us.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com